InvestorsHub Logo

Seaheck

06/12/17 5:05 PM

#14608 RE: Craig305 #14607

There are different kinds of diabetes. Type 1 & 2 as well as gestational. Juvenile diabetes is growing exponentially in this country especially.

Over 40,000,000 people in the US alone have some phase of diabetes. Multiply that by a World need and that's a HUGE number!! $$$$$$$

midas716

06/12/17 5:31 PM

#14613 RE: Craig305 #14607

You are correct that is an issue.

My bets are on this:

IMO. If ENDV's tech is proven effective and depending upon how many medicines ENDV's tech can replace I'm pretty confident a large pharma company that produces medicinal sales for heart, diabetes etc. etc. will buy out ENDV and shelve the patents and technology for 20 years or more. Why? Because big pharma makes too much money treating the symptoms of disease instead of actually curing disease.

Also pretty confident Mann and his cronies would take $2.00 a share right now if they can prove it works. I doubt there would be a bidding war. If it works no pharma company would want this tech to see the light of day. So if pharma "A" bids $2.00 a share they will tell pharma "B" ,"C" and "D" not to bid because they are shelving the tech for 20 years. Heck they may even pool money together just to get it shelved.

Don't say it can't happen. JP Morgan (Big Oil at the time) pulled funding from a full scale working Tesla Coil located in Shoreham Long Island that could light light bulbs without wires at least 300 yards away. Tesla was then found dead and the FBI confiscated all of his notes and journals never to be seen again.

That's how big business (sometimes) works. Deals are made under the table everyday.